Elute's Unattributed Round

Elute raised a round of funding on March 31, 2016.

Elute aims to be the leader in the development and commercialization of a new class of drug eluting devices designed for controlled and sustained release of drugs aimed at preventing and treating bone…

Articles about Elute's Unattributed Round: